Literature DB >> 19582176

Inflammation and anaemia as predictors of cardiovascular mortality in hemodialysis patients.

G Selim1, O Stojceva-Taneva, N Ivanovski, K Zafirovska, A Sikole, L Trajcevska, A Asani, M Polenakovic.   

Abstract

BACKGROUND: Cardiovascular diseases are the most common causes of death among hemodialysis (HD) patients, yet the risk factors for these events have not been well established. Our study objective was to determine predictors of cardiovascular mortality, considering the non-traditional/disease-related and treatment-related/ cardiovascular risk factor in HD patients.
MATERIAL AND METHODS: Disease-related cardiovascular risk factors, such as anaemia, calcium-phosphate disorders, nutrition-inflammation and treatment/dialysis-related cardiovascular risk factors such as HD dose, using the index Kt/V were analyzed in 214 patients on HD. Mortality was monitored prospectively over a two year period.
RESULTS: Fifty-three of the 214 HD patients died during the follow-up period and the main cause of death was cardiovascular events (56.6%), followed by infection/sepsis (26.4%). The patients who died were significantly older than those alive, had significantly lower serum levels of hemoglobin (Hb), albumin and Kt/V. Serum levels of calcium, C-reactive protein (CRP) and fibrinogen were significantly higher in patients who died during the follow-up period. Kaplan-Meier analysis showed that the all cause and cardiovascular mortality was considerably higher in patients with Hb<110 g/l, albumin <40 g/l, CRP>8 mg/l and spKt/V<1.2 (log rank, p=0.000/p=0.000, p=0.000/ p=0.001, p=0.000/p=0.000, p=0.000/p=0.000), respectively. No difference in cardiovascular mortality was observed between the fibrinogen <4 g/l> levels. High CRP, low Hb levels and low spKt/V were significant predictors of all-cause mortality, but low albumin and high fibrinogen levels were not in the Cox proportional hazards analysis. When only cardiovascular mortality was entered into the Cox model, high CRP and low Hb levels were the only significant predictors for mortality.
CONCLUSIONS: It can be concluded that, inflammation (elevated CRP) and anaemia (decreased Hb), were identified as significant independent non-traditional, disease-related cardiovascular risk factors that predict cardiovascular mortality in HD patients.

Entities:  

Keywords:  CRP; cardiovascular mortality; hemodyalisis; non-traditional cardiovascular risk factor

Year:  2007        PMID: 19582176      PMCID: PMC2464264     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  18 in total

1.  Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS.

Authors:  Trinh B Pifer; Keith P McCullough; Friedrich K Port; David A Goodkin; Bradley J Maroni; Philip J Held; Eric W Young
Journal:  Kidney Int       Date:  2002-12       Impact factor: 10.612

Review 2.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

3.  Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling.

Authors:  Giovanni Tripepi; Francesca Mallamaci; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2005-03       Impact factor: 10.121

4.  Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients.

Authors:  A K Cheung; M J Sarnak; G Yan; J T Dwyer; R J Heyka; M V Rocco; B P Teehan; A S Levey
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

5.  Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.

Authors:  Eric W Young; Justin M Albert; Sudtida Satayathum; David A Goodkin; Ronald L Pisoni; Takashi Akiba; Tadao Akizawa; Kiyoshi Kurokawa; Jürgen Bommer; Luis Piera; Friedrich K Port
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

6.  Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials.

Authors:  Giovanni F M Strippoli; Jonathan C Craig; Carlo Manno; Francesco P Schena
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

7.  The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.

Authors:  A Besarab; W K Bolton; J K Browne; J C Egrie; A R Nissenson; D M Okamoto; S J Schwab; D A Goodkin
Journal:  N Engl J Med       Date:  1998-08-27       Impact factor: 91.245

8.  Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.

Authors:  J Zimmermann; S Herrlinger; A Pruy; T Metzger; C Wanner
Journal:  Kidney Int       Date:  1999-02       Impact factor: 10.612

9.  Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Francesco Locatelli; Ronald L Pisoni; Christian Combe; Juergen Bommer; Vittorio E Andreucci; Luis Piera; Roger Greenwood; Harold I Feldman; Friedrich K Port; Philip J Held
Journal:  Nephrol Dial Transplant       Date:  2004-01       Impact factor: 5.992

10.  Effect of dialysis dose and membrane flux in maintenance hemodialysis.

Authors:  Garabed Eknoyan; Gerald J Beck; Alfred K Cheung; John T Daugirdas; Tom Greene; John W Kusek; Michael Allon; James Bailey; James A Delmez; Thomas A Depner; Johanna T Dwyer; Andrew S Levey; Nathan W Levin; Edgar Milford; Daniel B Ornt; Michael V Rocco; Gerald Schulman; Steve J Schwab; Brendan P Teehan; Robert Toto
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

View more
  3 in total

1.  A linear relationship between serum high-sensitive C-reactive protein and hemoglobin in hemodialysis patients.

Authors:  Behzad Heidari; Muhammad Reza Fazli; Muhammad Ali Ghazi Misaeid; Parham Heidari; Niloofar Hakimi; Abbas Ali Zeraati
Journal:  Clin Exp Nephrol       Date:  2014-11-08       Impact factor: 2.801

2.  Prediction model for cardiovascular disease risk in hemodialysis patients.

Authors:  Xu You; Ying Yue Huang; Ying Wang; Ming Xue Yu; Xiang Yong Li; Lin Xu; He Qun Zou
Journal:  Int Urol Nephrol       Date:  2021-09-06       Impact factor: 2.370

3.  Plasma fibrinogen and mortality in patients undergoing peritoneal dialysis: a prospective cohort study.

Authors:  Jing Yu; Tong Lin; Naya Huang; Xi Xia; Jianbo Li; Yagui Qiu; Xiao Yang; Haiping Mao; Fengxian Huang
Journal:  BMC Nephrol       Date:  2020-08-17       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.